Yang et al. also reported that C646, a histone acetyltransferase inhibitor attenuates peritoneal fibrosis by blocking the TGF-β1/Smad3 signaling pathway [38]. The gene discussed is TGFB1; the disease is Peritoneal Fibrosis.